Elastomeric Infusion Pumps Market To Reach $3.1 Billion by 2033

The report “Elastomeric Infusion Pumps Market By Product (Continuous Rate, Variable Rate), By Application (Pain Management, Chemotherapy, Antibiotic/Antiviral Therapy, Others), By End-Use (Hospitals, Ambulatory Surgical Centers, Others)” is expected to reach USD 3.1 billion by 2033, registering a CAGR of 9.90% from 2026 to 2033, according to a new report by Transpire Insight.

Increasing cases of chronic diseases like Cancer, Diabetes, and cardiovascular diseases have been an important factor driving the market. As per statistics provided by the World Health Organization, Chronic Diseases have been recognized as the major reason for fatalities across the globe, constituting 71% for all fatalities. Osteomyelitis affects about 50,000 people in the U.S. each year, most predominantly among children, older people, and males, according to a study published in October 2024. Increasing demand for home-based patient care is an extremely critical factor propelling the market for Elastomeric Infusion Pumps. Patients have been preferring those therapies which will help them to self-administer medicines, for which Elastomeric Infusion Pumps have increased patient appeal. Rising demand for home-based patient care is an extremely critical factor propelling the market for Elastomeric Infusion Pumps. Vertebrae and long bones are known to be the frequent sites. It also indicates that males are more vulnerable to cases of Osteomyelitis than females, as can be seen in the present study and the various pieces of information available in literature regarding this disease. Companies are trying to improve elastomeric infusion pump technology to promote the growth of the market. These developments include greater precision, longer time for infusions, improving pumps with enhanced characteristics, and affordable designs. In September 2024, a research work published in the Journal of Biosciences and Medicines proposed a theoretical model of elastomeric pumps that dispense drugs using a catheter. Elastomeric pumps can nicely simulate clinical infusion rates and describe a toxicity hump based on the spherical body's radius accurately. They concluded that through optimized characteristics, the time period for infusion can be controlled and toxicity can be avoided to some extent.

The Continuous Rate segment is projected to witness the highest CAGR in the Sensor-based Ore Sorting Market during the forecast period.

The widespread use of the continuous rate elastomeric infusion pumps can be attributed to the controlled distribution of the drug, making these pumps the best choice for drug delivery in situations which involve constant drug administration, for instance, antibiotics and pain management. Ease of use, coupled with their efficiency, were major attributes that contributed to their major market share.

Continuous rate pumps are gaining popularity in hospitals and home healthcare settings for their reliability and ease of use, thereby propelling the market. In April 2024, Baxter International Inc. launched innovative elastomeric infusion pumps with better durability and usability features, marking its presence in the infusion treatment solutions market.

The Pain Management segment is projected to witness the highest CAGR in the Sensor-based Ore Sorting Market during the forecast period.

Based on treatment, the market is further categorized into pain management, antibiotic or antiviral, and chemo. Out of these, the pain management treatment segment accounts for the major share in the market. Rising cases of the problem of pain being experienced by people around the world have contributed to the increasing demand for effective pain treatments. Increasing geriatric population, prone to many chronic ailments, including the problem of pain, is majorly fueling the growth in the industry.

Elastomeric infusion pumps are widely used in pain control in both acute and chronic situations and enable patient self-administration of medications when needed and thus provide easy analgesic treatment to patients. A Journal of Pain Research study proved that elastomeric infusion pumps increased patient satisfaction and reduced the dose of opioids used when used in pain control in the post-operative setting.

The Hospitals segment is projected to witness the highest CAGR in the Sensor-based Ore Sorting Market during the forecast period.

The dominance of these pumps can be attributed to the fact that they are being largely utilized in various hospital settings, such as surgical, intensive care, and oncology units. The need for accurate and effective drug infusion systems in hospitals cannot be denied, particularly given the need for patient care in the post-operational, chemotherapy, and pain management settings. The elastomeric infusion pumps can cater effectively to this demand, since they have the capability for consistent drug infusion, ease of use, and the absence of chances of drug errors, unlike traditional IV infusion systems. For example, a study was conducted in the Journal of Pain Research in 2022, showing the effectiveness of elastomeric infusion pumps for post-operative pain management in terms of improved patient satisfaction and reduced opioid usage, indicating the rising demand for these pumps for pain management applications.

The North America region is projected to witness the highest CAGR in the Sensor-based Ore Sorting Market during the forecast period.

The market in North America is projected to be 41% of the market growth in the global market during the forecast period. The regional market trends and dynamics have been elaborately described in the report by the Technavio analysts. The superior healthcare setting, consisting of hospitals, medical care units, amongst others, in the North American market, uses infusion pumps for the accurate dispensation of medicines and liquids to patients. A strong healthcare setting in the North American market, along with a strong focus on patient safety, is driving the demand for elastomeric infusion pumps. The demographic inflow of a large number of aging people in the North American market, showing vulnerability towards chronic illnesses such as diabetes, heart diseases, and cancers, makes the use of elastomeric infusion pumps unavoidable for the treatment of such illnesses through insulin, chemotherapy medications, pain relievers, amongst others. The elastomeric infusion pumps possess benefits such as long-term stability testing, power consumption analysis, patient safety, and drug dispensation systems.

Key Players

The top 15 players in the Positron Emission Tomography Market include ACE Medical, Ambu, Avanos, B. Braun, Baxter, Fresenius Kabi, Halyard, ICU Medical, JMS, KB Medical, Leventon, Nipro, Smiths Medical, Terumo, Woo Young Medical.

Drop us an email at:

inquiry@transpireinsight.com

Call us on:

+91 7666513636